EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Roles of osteoclasts in pathological conditions

Sohei Kitazawa, Ryuma Haraguchi, Riko Kitazawa

Pathology International · 2025

DOI: 10.1111/pin.13500 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology International, 2025. Verfasst von Sohei Kitazawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Japan. Hauptthemen laut MEDLINE: Osteoclasts, Bone Resorption. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone is a unique organ crucial for locomotion, mineral metabolism, and hematopoiesis. It maintains homeostasis through a balance between bone formation by osteoblasts and bone resorption by osteoclasts, which is regulated by the basic multicellular unit (BMU). Abnormal bone metabolism arises from an imbalance in the BMU. Osteoclasts, derived from the monocyte‐macrophage lineage, are regulated by the RANKL‐RANK‐OPG system, which is a key factor in osteoclast differentiation. RANKL activates osteoclasts through its receptor RANK, while OPG acts as a decoy receptor that inhibits RANKL. In trabecular bone, high turnover involves rapid bone formation and resorption, influenced by conditions such as malignancy and inflammatory cytokines that increase RANKL expression. Cortical bone remodeling, regulated by aged osteocytes expressing RANKL, is less understood, despite ongoing research into how Rett syndrome, characterized by MeCP2 abnormalities, affects RANKL expression. Balancing trabecular and cortical bone involves mechanisms that preserve cortical bone, despite overall bone mass reduction due to aging or oxidative stress. Research into genes like sFRP4, which modulates bone mass, highlights the complex regulation by BMUs. The roles of the RANKL‐RANK‐OPG system extend beyond bone, affecting processes such as aortic valve formation and temperature regulation, which highlight the interconnected nature of biological research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsBone ResorptionHumansAnimalsRANK LigandBone and BonesBone RemodelingReceptor Activator of Nuclear Factor-kappa BOsteoprotegerin

Stichwörter der Autor:innen

BMUDNA methylationRANKLbone resorptionosteoclastssFRP4

Substanzen

RANK LigandReceptor Activator of Nuclear Factor-kappa BOsteoprotegerin

Autor:innen und Institutionen

  • Department of Molecular Pathology, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Japan.
  • Division of Diagnostic Pathology, Ehime University Hospital, Shitsukawa, Toon City, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kitazawa, S., Haraguchi, R., & Kitazawa, R. (2025). Roles of osteoclasts in pathological conditions. Pathology International. https://doi.org/10.1111/pin.13500

Vancouver

Kitazawa S, Haraguchi R, Kitazawa R. Roles of osteoclasts in pathological conditions. Pathology International. 2025. doi:10.1111/pin.13500

BibTeX
@article{Kitazawa2025,
  author = {Kitazawa, Sohei and Haraguchi, Ryuma and Kitazawa, Riko},
  title = {Roles of osteoclasts in pathological conditions},
  journal = {Pathology International},
  year = {2025},
  doi = {10.1111/pin.13500}
}
Kostenlos starten →